Correlation Between Vaccinex and Rxsight
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Rxsight at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Rxsight into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Rxsight, you can compare the effects of market volatilities on Vaccinex and Rxsight and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Rxsight. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Rxsight.
Diversification Opportunities for Vaccinex and Rxsight
Poor diversification
The 3 months correlation between Vaccinex and Rxsight is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Rxsight in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rxsight and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Rxsight. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rxsight has no effect on the direction of Vaccinex i.e., Vaccinex and Rxsight go up and down completely randomly.
Pair Corralation between Vaccinex and Rxsight
Given the investment horizon of 90 days Vaccinex is expected to generate 3.01 times more return on investment than Rxsight. However, Vaccinex is 3.01 times more volatile than Rxsight. It trades about 0.02 of its potential returns per unit of risk. Rxsight is currently generating about -0.12 per unit of risk. If you would invest 374.00 in Vaccinex on August 28, 2024 and sell it today you would lose (18.00) from holding Vaccinex or give up 4.81% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.45% |
Values | Daily Returns |
Vaccinex vs. Rxsight
Performance |
Timeline |
Vaccinex |
Rxsight |
Vaccinex and Rxsight Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and Rxsight
The main advantage of trading using opposite Vaccinex and Rxsight positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Rxsight can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rxsight will offset losses from the drop in Rxsight's long position.Vaccinex vs. Eliem Therapeutics | Vaccinex vs. HCW Biologics | Vaccinex vs. Scpharmaceuticals | Vaccinex vs. Milestone Pharmaceuticals |
Rxsight vs. Axogen Inc | Rxsight vs. Treace Medical Concepts | Rxsight vs. Pulmonx Corp | Rxsight vs. Orthofix Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |